Home Newsfeeds BayCom Q2 EPS $0.38 Down From $0.49 YoY

BayCom Q2 EPS $0.38 Down From $0.49 YoY

BayCom (NASDAQ:BCML) reported quarterly earnings of $0.38 per share. This is a 22.45 percent decrease over earnings of $0.49 per share from the same period last year.

byBill Haddad

July 21, 2022

1 minute read

BayCom (NASDAQ:BCML) reported quarterly earnings of $0.38 per share. This is a 22.45 percent decrease over earnings of $0.49 per share from the same period last year.

Eliem Therapeutics Outlines Interim Data From Early-Stage Depressive Study

By Vandana Singh

October 5, 11:20 AM

Eliem Therapeutics Inc (NASDAQ:ELYM) announced interim results from its ongoing Phase 1 trial of ETX-155 for major depressive disorder (MDD) and…

ELYM

Ahead Of Semiconductor Earnings, Analysts Expect AI To Serve As ‘Shining Pillar’ To Guide Through Muted Chip Demand

By Shanthi Rexaline

July 24, 12:25 PM

The tech earnings season gets started in earnest this week and besides AI-levered bellwether stocks such as Alphabet,…

AMC

HC Wainwright & Co. Maintains Buy on Celularity, Lowers Price Target to $2.5

By Benzinga Newsdesk

January 30, 7:43 AM

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Celularity (NASDAQ:CELU) with a Buy and lowers the price target from $15 to $2.5.

CELU

Warren Buffett Diversifies Beyond Apple: Berkshire Hathaway’s Financial Sector Bets

By Surbhi Jain

November 16, 1:12 PM

Investors may want to look beyond Apple Inc when assessing Warren Buffett's portfolio holdings. Here's what Berkshire Hathaway is investing in beyond Apple and Tech.

AAPL

BayCom Q2 EPS $0.38 Down From $0.49 YoY

Related Posts

Eliem Therapeutics Outlines Interim Data From Early-Stage Depressive Study

Ahead Of Semiconductor Earnings, Analysts Expect AI To Serve As ‘Shining Pillar’ To Guide Through Muted Chip Demand

HC Wainwright & Co. Maintains Buy on Celularity, Lowers Price Target to $2.5

Warren Buffett Diversifies Beyond Apple: Berkshire Hathaway’s Financial Sector Bets